key: cord-0962090-u8673b9h
authors: Harzallah, Inès; Debliquis, Agathe; Drénou, Bernard
title: Frequency of lupus anticoagulant in Covid‐19 patients
date: 2020-05-29
journal: J Thromb Haemost
DOI: 10.1111/jth.14937
sha: d6bf542c04198f02fcc5c91377e4b99a8bffe661
doc_id: 962090
cord_uid: u8673b9h

We have recently published in the Journal of Thrombosis and Haemostasis the presence of lupus anticoagulant (LAC) at high frequency in Covid‐19 patients (Harzallah et al.(1)). Bowles et al.(2) and Helms et al.(3) have confirmed these results in new publications. Tang(4) has reported discordant data. He has found that very few tested covid‐19 patients had positive LAC in a small series (n=12). Bowles et al. have found that LAC were positive in 91% of patients (n=34) with high activated partial thromboplastin time (aPTT).

We have recently published in the Journal of Thrombosis and Haemostasis the presence of lupus anticoagulant (LAC) at high frequency in Covid-19 patients (Harzallah et al. 1 Heparin activity was higher than 0.5 U/mL with dRVVT test and 0.05 U/mL with SCT test.

With these series (1, 2, 3) we can affirm that LAC is frequent in Covid-19 patients. However the relation between the presence of LAC and thrombosis must be studied. This article is protected by copyright. All rights reserved Accepted Article

Lupus anticoagulant is frequent in patients with Covid-19

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

Lupus anticoagulant is frequent in patients with Covid-19